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A series of fluorine-18 and lodme-125 labeled aryl-1,4-dlalkylplperazme analogs, derivatives of GBR 
12935, were synthesized as radiotracers for positron emlsslon tomography or single photon emlsslon 
computerized tomography imaging of the brain based on their affinity for the presynaptlc dopamme 
reuptake system High specific actlvlty fluorme-18 tracers were prepared by nucleophlhc aromatic 
substltutlon reactions, Iodine-125 tracers were prepared by lsotoplc exchange reactions In vitro competl- 
tlve bmdmg studies demonstrated that lodme substitution IS tolerated m the 4-posltlon of the phenyl ring 
of the phenalkylplperazme group In vwo regional brain blodlstrlbutlon studies m mice indicated no 
selectlvlty of the radlolodmated hgands for the dopamme reuptake site, with strlatum/cerebellum 
concentration ratios of 1. Slmllar negative results with the new fluorine-18 derlvatlves demonstrated that 
m VZWJ selectlvlty for the dopamme reuptake site appears to be crItIcally dependent on the carbon chain 
length between the plperazme rmg and the solitary aromatic rmg These studies suggest that development 
of new radlopharmaceutlcals based on the GBR 12935 structure cannot be based solely on conslderatlons 
of m ut~ro bmdmg affinities 
Introduction 
Potent, highly selective dopamme reuptake mhibitors 
m the aryl- 1,4-dialk(en)ylptperazme series (Scheme 1) 
have been recently reported (van der Zee et al, 1980) 
An interesting feature of this class of compounds IS 
their higher selectivity for the dopammergic uptake 
system than for the noradrenergic or serotonmergic 
uptake systems compared to previously reported 
dopamme reuptake inhibitors such as nomtfensme, 
mazindol and cocame. The latter compounds also 
have the disadvantage of being potent releasers of 
dopamme, a property not shared by the aryl-1,4- 
dtalk(en)ylpiperazmes (Hoffman et al., 1986). Studies 
conducted with a phenylpropenyl derivative, 
[3H]GBR 12783 (Chagraout et al, 1987; Leroux- 
Nicollet and Costentin, 1988), and the phenylpropyl 
derivatives [“F]GBR 13119 (Ktlbourn, 1988) and 
[‘*F]GBR 12909 (Haka et al., 1989), have demon- 
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strated that these compounds retam their high affinity 
and specificity for the dopamme reuptake system m 
uzuo [l*F]GBR 12909 has been recently used to image 
the presynapttc dopamme reuptake system m the 
human bram using positron emission tomography 
(PET) (Koeppe et al, 1990) An I-125 labeled aztdo 
analog m this series was also recently reported to be 
a potential photoaffimty label for the dopamme 
uptake carrier protein (Grigoriadis et al, 1989) An 
important observation was the high WI mtro potency 
(K, = lo-20 nM) displayed by this particular analog 
despite the mcorporation of an iodine atom and an 
azido group m the 3 and 4 posittons, respectively, of 
the solitary aromatic rmg. Encouraged by these re- 
sults, we have pursued the development of new 
radiotracers based on this series of compounds, and 
m particular radioiodmated analogs which might find 
more widespread clinical use due to the greater 
availability of single photon emission computed 
tomography (SPECT) mstrumentatton. 
Examination of the single limited SAR study of the 
aryl- 1,4-dtalkylpiperazmes revealed that analogs 
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Scheme 1 
bearmg small-volume halogen substituents on the 
aromatic rings led to highly potent mhibitors (van der 
Zee et al., 1980) No significant reduction m dopa- 
mme reuptake mhtbition resulted from replacement 
of the phenylpropenyl portion of GBR 12783 with a 
phenylpropyl group (GBR 12935) and furthermore, 
phenethyl or phenylbutyl groups caused only slight 
decreases m potency (van der Zee et al. 1980) 
Our goal m this work was twofold 
(1) to explore the effect of shortening the carbon 
chain length between the sohtary aromatic 
nng and the piperazme nng on m vluo specifi- 
city for the dopamme reuptake system; and 
(2) to determine if analogs labeled with iodme- 
125 on an aromatic rmg would retam the high 
affinity and specificity displayed by the parent 
compounds. 
The radiofluormated derrvatives [18F]3a and [18F]3b 
and the radioiodmated analogs [‘*‘1]8a, [“‘1]8b, 
[1251]8e and [‘*‘I]12 were synthesized and their regional 
zn vluo brain distribution m CD-1 mice were com- 
pared to [‘*F]GBR 13119 and [“F]GBR 12909, the 
[‘*F]fluormated hgands currently bemg evaluated m 
PET studies of the dopamme reuptake system 
Experimental 
Melting pomts were obtained with a Fisher-Johns 
melting point apparatus and are uncorrected Infra- 
red spectra were recorded on a Perkn-Elmer 727B 
spectrometer. ‘H-NMR spectra were obtained on a 
Bruker WM-360 (360 MHz) instrument with tetra- 
methylsilane as internal standard. Mass spectra were 
obtained on a Fmmgan 4021 GCMS/DS (low resol- 
ution) or a UG70-250-S (high resolution) instrument 
3-Iodophenylacetic acid was purchased from Sapon 
Laboratories, Aurora, OH All other chemical 
reagents were purchased from Aldrich Chemical 
Company, Milwaukee, WI Flash chromatography 
was performed by the method of Still et al (1978) 
Elemental analyses were performed by Spang, 
Microanalytical Laboratories, Eagle Harbor, MI 
Thin-layer chromatography of the radioacttve 
products was performed on either Whatman K6F 
srhca gel glass-backed plates (20 cm, 250 pm) or 
Whatman KC1 8F reversed phase glass-backed plates 
(20 cm, 200 pm) TLC chromatograms were scanned 
for radioactivtty using a Berthold Model LB 2832 
TLC-linear analyzer equipped with a Model LB 500 
data acquisition system. 
HPLC was carried out on a Beckmann Instrument 
Model 344 hqmd chromatograph equipped with a 
Beckman Model 155-00 u.v detector Radioactivity 
was monitored with either a Beckman Model 170 
radioisotope detector or a Radiomatic Instruments 
Model DR/IC Flo-one radioactive flow detector with 
a Model CU data acquisition system upgrade con- 
taming a 340 PL solid scmtillant cell For the punfi- 
cation of the I-125 labeled tracers a Phenomenex 
Ultremex C-l 8, 5 pm (4 6 x 150 mm) column was 
used with 0 1 M ammonium acetate, pH = 6 8 (A) 
and 95% ethanol (B) mixtures under the followmg 
conditions For [‘251]8a A.B 1:4; flow rate I mL 
mm ‘, retention time 10 6 mm; For [‘*‘1]8b A B 1 4, 
flow rate 1 5 mL min’; retention time 11 0 mm For 
[“51]8c A B 13 87, flow rate 1.2 mL min’ , retention 
time 7 0 mm For [1251]12 A B 15 85, flow rate 1 mL 
min-‘, retention time 9 0 mm. Ultraviolet ab- 
sorbance was monitored at 233 nm m the above 
cases Specific activity determmattons for the radio- 
iodmated tracers [‘*‘1]8a, [‘*‘1]8b and [‘251]8c were 
estimated from a standard curve relating mass to 
u v absorbance peak area as described previously 
(Van Dort et al., 1988) utihzmg the HPLC conditions 
described above For [‘25I]12 a p Bondapak cyano 
column, 10 pm, (3 9 x 300 mm) was used with 0 1 M 
ammomum acetate (pH = 6 8). acetomtrile (1 1) at a 
flow rate of 2 mL min ’ and u.v detection at 237 nm 
The retention time of [‘*‘I]12 was 7.9 mm under these 
conditions 
High specific activity, no-carrier-added [‘*F]- 
fluoride ion was prepared by irradratton of a [‘*O]- 
water target, as previously described (Mulholland 
et al, 1989) Na[lZ51] iodide was obtained from 
Nordion Ltd, Ontario, Canada as a no-carrier-added 
solution m 0 1 N NaOH (pH = 10-12) 
Preparatron of I-(2-hydroxyethyl)-4-(benzyl)-plper- 
ame (2a) and I-(2-h,vdroxyethyl)-4-(2_phenylethyl)- 
plperazme (2b) 
Synthesis of these intermediate alcohols was based 
on methods previously reported (van der Zee et al, 
1980) 1-(2-Hydroxyethyl)piperazine (1 equiv.) in 
ethanol was condensed with the appropriate halide 
[benzyl chloride or 2-bromoethylbenzene (1 eqmv)] 
under reflux conditions The crude mixture was evap- 
orated and the product isolated by repeated hqutd- 
liquid extractions (chloroform. 2 N HCl, followed by 
partitionmg between 6 N NaOH chloroform) The 
final organic layer was washed with brme and dried 
(Na,SO,). The isolated products were suitable for use 
m the subsequent condensation reactions 
I -(2-Hydroxyethyl)-4-(benzyllplperazme 2(a) 
‘H-NMR (free base, CDCI,) 6 7.24-7 32 
(m. 5H, Ar), 3 62 (t, 2H, -CH2-OH), 3 57 (s, 2H, 
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benzyhc), 2.51-2.66 (m, lOH, -NCH,) EIMS 
(70 eV), m/e (rel. mt.): 220 (M +, 2.2) 202 (9.8), 190 
(24.8), 189 (47.8), 146 (11.4), 134 (6.2), 119 (8.4), 98 
(7.3), 91 (100). 
1-(2-Hydroxyethyl)-4-(2-phenylethyl)plpera.zme (2b) 
‘H-NMR (free base, CDCl,) 6: 7 17-7.32 
(m, 5H, Ar), 3 61 (t, 2H, -CH,-OH), 2.78-2 84 
(dd, 2H, benzyhc), 2.48-2.63 (m, 12H, -NCH2). 
EIMS (70 eV), m/e (rel mt.): 234 (M +, 0.68), 189 (1) 
160 (224), 143 (100). 
Synthesu of I -[2- {(4’-[“F]j?uorophenyl)(jhenyl) 
methoxyjethyl]-4-(benzyllplperazme (3a) and 1-[2- 
{(4’ - [‘8Ffluorophenyl)(phenyl)methoxy/’ethyl]- 4- (2- 
phenylethyl)plperazme (3b) 
These fluorme-18 labeled derivatives were prepared 
m a manner identical to that recently described for 
[‘*F]GBR 12909 and [18F]GBR 13119 (Kilbourn and 
Haka, 1988). In brief, 4-[“Flfluorobenzhydryl 
chloride (1) was prepared m no-carrier-added form 
through a three step reaction: nucleophihc substi- 
tution of the mtro group m 4-mtrobenzophenone 
with F-18, reduction of the ketone to the alcohol 
followed by chlorination with SOCI,. 1 was then 
condensed with the appropriately substituted 2- 
hydroxyethylpiperazme derivative to give 3a* 
(Scheme 2) The products were isolated by silica gel 
Sep-Pak chromatography, and radiochemical purities 
and specific activities determined by TLC and HPLC 
Isolated products were prepared for rn LVUO studies by 
evaporation of organic solvent and dissolution m 
0 9% bacteriostatic saline contammg up to 10% 
ethanol 
2-(3-Iodophenyl)ethanol (51) 
A solution of 3-iodophenylacetic acid 4a (I 0 g, 
3.82 mmol) in dry THF (5 mL) was treated dropwise 
with stirrmg at 0°C under argon with a 1 0 M solution 
of BH, m THF (4 96 mL, 4.96 mmol). The solution 
was stirred at 0” to 5°C for 1 h and the excess BH, was 
n 
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Scheme 2 
destroyed by treatment dropwise at 0°C with a sol- 
ution of 3 mL of THF H,O (1: 1). The reaction 
mixture was poured mto saturated aqueous K,C03 
(25 mL), extracted with Et,0 (3 x 25 mL) and the 
organic layers dned (MgSO,), filtered and evapor- 
ated. Purification by flash chromatography (silica gel, 
CHCI,: CH,OH, 97: 3) yielded 0.92 g (97%) of pure 
5a as a colorless oil: ‘H-NMR (CDCl,) 6: 7.60 (s, lH), 
7.57 (d, lH, J = 7 8 Hz), 7 20 (d, lH, J = 7.6 Hz), 7 05 
(t, IH, J = 7 7 Hz), 3.85 (t, 2H, J = 6 5 Hz), 2.81 
(t,2H, J=6.5Hz), 145 (brs, 1H) HRMS m/e 
247.9685 (C,H,IO requires 247.9698). EIMS (70 eV) 
m/e (relative intensity) 248 (M +, base) 218(56), 
217(58), 91(69), 90(52), 89(29), 86(18), 84(26), 77(15), 
65(15), 63(17), 49(30), 39(15). 
3-(3-Iodophenyl)propanol (56) 
Similarly, diborane reduction of 3-(3-iodo- 
phenyl)propionic acid 4b gave 5b m 95% yield. 1.r. 
(NuJo~) 3330 cm-’ (OH); ‘H-NMR (CDCI,) 6 7 57 
(s, lH), 7 53 (d, lH, J= 7.9Hz), 7.16 (d, lH, J= 
7 9 Hz), 7 02 (t, lH, J = 7 7 Hz), 3 67 (t, 2H, J = 
6 4 Hz), 2.66 (t, 2H, J = 7 7 Hz), 1.91-1.83 (m, 2H), 
134 (brs, IH). HRMS m/e 261 9851 (CgH,,iO re- 
quires 261.9855). EIMS (70eV) m/e (relative inten- 
sity) 264(13), 262(98), 244(61), 218(56), 217(36), 
117(84), 115(34), 104(41), 103(27), 9l(base), 90(42), 
89(29), 78(28), 77(34), 51(23), 43(29). 
3-(4-1odophenyl)propanol (~5) 
By a similar approach diborane reduction of 3- 
(4-iodophenyl)propiomc acid 4c gave 5c m 95% 
yield. ‘H-NMR (CDCl,) 6: 7.59 (d,2H, J = 
8 3 Hz), 6 94 (d, 2H, J = 8 3 Hz), 3.64 (t, 2H, J = 
6 40 Hz), 2 65 (t, 2H, J = 7 41 Hz), 1.87-1 83 (m, 2H), 
1 58 (brs, IH). HRMS m/e 261.9847 (C,H,,IO re- 
quires 261 9855) EIMS (70eV) m/e (relative mten- 
sity) 262(12), 244(10), 217(10), 117(10), 91(9), 74(23), 
73(24), 71(9), 61(14), 59(36), 45(base), 43(43), 42(18), 
41(20) 
2-(3-Iodophenyl)ethyl tosylate (&z) 
A stirred solution of the alcohol 5a (0.74 g, 
2 98 mmol) and pyridme (0 56 g, 7 15 mmol) m dry 
CH,Cl, (5 mL) was treated under argon with p-tolu- 
enesulfonyl chloride (0.68 g, 3.58 mmol) m one por- 
tion at O’C The reaction was allowed to warm to 
room temperature and stirred a further 3 h. Volatiles 
were removed under high vacuum and the residue 
partitioned between saturated aqeuous NaHCO, 
(25 mL) and EtOAc (25 mL). The aqueous layer was 
further extracted with EtOAc (2 x 25 mL), the com- 
bmed organic layers washed with H,O (25 mL) and 
dried (Na,SO,) The solvent was evaporated and 
the residue flash chromatographed (silica-gel, hex- 
anes . EtOAc, 3.1) to afford 1.05 g (87%) of pure 6a 
as a colorless oil. ‘H-NMR (CDCI,) 6: 7.66 (d, 2H, 
J = 8 3 Hz), 7.54 (d, lH, J = 7 8 Hz), 741 (s, lH), 
7.29 (d, 2H, J = 8.3 Hz), 7.09 (d, lH, J = 7.6 Hz), 6.98 
(t, lH, J = 7 7 Hz), 4 19 (t, 2H, J = 6 7 Hz), 2 88 (t, 
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2H, J = 6.7 Hz), 2 44 (s, 3H) HRMS m/e 401.9779 
(C,,H,,ISO, requires 401.9787) EIMS (70eV) m/e 
(relative mtenstty) 405(2), 231( 1 l), 230(base), 217( 18) 
155(11), 103(16), 91(40), 90(17), 65(13) 
3-(3-Iodophenyl)propyl tosylate (65) 
Similarly tosylatton of alcohol 5b gave 6b m 75% 
yield ‘H-NMR (CDCl,) 6. 7 79 (d, 2H, J = 8 1 Hz), 
7.51 (d, lH, J = 7 7 Hz), 7.44 (s, IH), 7.35 (d, 2H, J = 
8 3Hz) 704 (d, lH,J=7 6Hz), 697 (t, lH, J= 
7 7 Hz), 4 02 (t, 2H, J = 6 1 Hz), 2.59 (t, 2H, 
J = 7.6 Hz), 2 46 (s, 3H), 1 97-l 89 (m, 2H) HRMS 
m/e 415 9932 (C,,H,,ISO, requires 415 9943). EIMS 
(70 eV) m/e (relative intensity) 416(20), 245(12), 
244(base),217(10), 118(15), 117(46), 115(13), 104(10), 
91(33), 65(10) 
3-(4-Iodophenyl)propyl tosylate (6a) 
Stmtlarly tosylatton of alcohol 5c gave 6c m 86% 
yield ‘H-NMR (CDCI,) 6 7 77 (d, 2H, J = 8 2 Hz), 
7 54 (d, 2H, J = 8 2 Hz), 7 35 (d, 2H, J = 8.4 Hz), 6 82 
(d, 2H, J = 8 1 Hz), 4 00 (t, 2H, J = 6 1 Hz), 2 60 
(t, 2H, J = 7 4 Hz), 2 47 (s, 3H), 1 92 (pentet, 2H, 
J = 7.7 Hz) HRMS m/e HRMS m/e 415 9934 
(C,,H,,ISOJ requires 415 9943) EIMS (70eV) m/e 
(relative Intensity) 416(7), 245( 13) 244(base), 217( 13) 
118(9), 117(43), 116(9), 115(17), 104(11). 103(7), 
91(25), 90(12), 89(8). 78(7), 77(8), 65(11) 
I-[Z-{Dlphenylmethoxyjethyl]plperazme (7) 
A well stirred mixture of piperazme (3 14 g, 
36.45 mmol) and K,CO, (3 36 g, 24 31 mmol) m dry 
toluene (10mL) was treated dropwise under reflux 
with a solution of benzhydryl fl-chloroethyl ether 
(van der Zee et al, 1980) (3 0 g, 12.16mmol) m 
toluene (10 mL) Followmg reflux for 5 h the cooled 
mixture was diluted with toluene (30 mL) extracted 
with Hz0 (2 x 50 mL) and the organic layers dried 
(Na,SO,) Flash chromatography (silica gel, 
CHCI, CH,OH NH,OH, 8 2 0 1) of the crude 
product gave 2 18 g (60%) of pure 7 as a colorless 011 
‘H-NMR (CDCI,) 6 7 36-7 21 (m, IOH), 5 37 (s, 
lH), 3 60 (t. 2H, J = 6 1 Hz), 2 89(t, 4H, J = 4 8 Hz), 
2 67 (t, 2H, J = 6 1 Hz), 2 50 (br, m, 4H), 2 11 (s. 1H) 
HRMS nz/e 297.1968 (C,,H,,N?O requires 297 
1967). CIMS (methane), m/e (relative mtenstty), 
297(78), 295(19), 195(14), 168(13). 167(base), 113(18), 
99(14), 86(12) 
I- {2- (Drphenylmethoxy)ethyl}- 4- (2- (3- lodophenyl) 
ethyl}plperazme (&I) 
The tosylate derivative 6a (0 27 g, 0.67 mmol) m 
dry toluene (3 mL) was added dropwise under argon 
to a warm (75C) stirred suspension of the ptperazme 
derivative 7 (0 2Og, 0 67 mmol) and anhydrous 
K,CO, (0.19 g, 1 35 mmol) m dry toluene (3 mL) The 
reaction mixture was refluxed for 24 h The cooled 
mixture was then poured mto H,O (25 mL) extracted 
with toluene (2 x 25 mL) and the combined organic 
layers washed with H20 (25 mL) and dried (Na,SO,) 
Flash chromatography (sthca gel, CHCl,: CH,OH, 
98: 2) of the crude product afforded 0.32 g (90%) of 
pure 8a as an 011 A portton of this material was 
converted to the dthydrochlortde salt by treatment of 
an ethanol solutton with ethereal HCl. Recrystalhza- 
tion from tsopropanol afforded white crystals m p 
204-206X (d). ‘H-NMR (free base, CDCI,) 6. 7 56 
(s, lH), 7 52 (d, lH, J = 7 7 Hz), 7 35-7 20 (m, lOH), 
7.15 (d, lH, J = 7.7 Hz), 7 00 (t, lH, J = 7.7 Hz), 5 37 
(s, lH), 3 60 (t, 2H, J = 6 1 Hz), 2 75-2 41 (m, 14H). 
Anal calcd for (C,,H3, N,IO 2HCl) C, 54.10, H, 
5 55, N, 4 67 Found: C, 54 18; H, 5 61, N, 4 61 
1- (2- (Dzphenylmethoxy)ethyl} - 4- {3- (3- rodophenyl) 
prop,vl}piperazme (sb) 
Simtlarly treatment of the ptperazme derivative 7 
with 3-(3-1odophenyl)propyl tosylate (6b) afforded 8b 
after workup m 60% yteld, m.p for the dthydrochlo- 
ride salt 185-186°C (d) (tsopropanol) ‘H-NMR (free 
base, CDCI,) 6 7 54 (s, 1 H), 7 49 (d, 1 H, J = 7 7 Hz), 
7 34-7 20 (m, lOH), 7.12 (d, lH, J = 7.7 Hz), 6 98 
(t, lH, J = 7 7 Hz), 5.37 (s, IH), 3 59 (t, 2H, J = 
6 1 Hz), 2 67 (t,2H, J = 6.0 Hz) 2 58-2.30 (m, 12H) 
1 76 (m, 2H) Anal calcd for (C,, H,, N,IO .2HC1). C, 
54 82, H, 5 75, N. 4 57 Found C, 54 88; H 5 66; N, 
4 53 
I- {2- (Dlphenylmethoxy)ethyfj- 4- {3- (4- lodophenyl) 
propyljplperazme (&) 
Similarly treatment of the piperazme derivative 7 
with 3-(4-1odophenyl)propyl tosylate (6e) afforded 8c 
after workup m 70% yield, m p for the drhydrochlo- 
rtde salt 190-192°C (d) (ethanol) ‘H-NMR (free 
base, CDCI,) 6 7 58 (d, 2H, J = 8 3 Hz), 7 35-7 21 
(m, lOH), 6.93 (d, 2H, J = 8.3 Hz), 5 37 (s, lH), 3 60 
(t, 2H, J = 6 1 Hz), 2 68 (t, 2H, J = 5 9 Hz), 2 58-2 31 
(m 12H), 1 77 (pentet, 2H). Anal calcd for 
(Cz,H3?N110 2HCl) C, 54 82, H, 5 75, N, 4 57. 
Found C, 54 81, H, 5 75, N, 445 
4-Fluoro-4’-lodobenzophenone (9) 
A well stirred suspension of 4-iodobenzoyl chloride 
(1 00 g, 3 75 mmol) m dry fluorobenzene (5 mL) un- 
der argon was treated with AICI, (1 00 g, 7 5 mmol) 
m one portion at room temperature Followmg 2 h of 
reflux the clear warm solutton was poured over a 
mixture of crushed ice and concentrated HCI The 
product was extracted mto CHCl, (3 x 25 mL) and the 
combined organic layers washed with aqueous 10% 
Na,CO, (75 mL), Hz0 (75 mL), and dried (Na,SO,). 
Followmg removal of solvent the residue was recrys- 
talhzed from EtOH to give 1 10 g (90%) of white 
shiny flakes, m.p 129-130°C. 1 r (KBr) 1640cm-‘, 
‘H-NMR(CDCl,)6,7 87-7 80(m, 4H),7 49(d, 2H, J = 
8 5 Hz), 7 17 (m, 2H) Anal calcd for (C,,H,FIO) C, 
47 88; H, 2 47 Found C, 47 74, H, 2 61 
4-Fluoro-4’-lodobenzhydrol (10) 
Asolutionof9(1 Og,3 1 mmol)mdryTHF(lOmL) 
was treated dropwise with stirrmg at O-SC with a 
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1 0 M solution of BH, m THF (4.0 mL, 4.0 mmol). 
The solution was allowed to warm to room temperature 
and stirred a further 3 h. The excess BH, was de- 
stroyed by treatment dropwtse at 0°C with a solution 
of 25 mL of THF. H,O (1: 1). The reaction mixture 
was poured mto saturated aqueous K,CO, (50 mL), 
extracted with Et,0 (3 x 50 mL) and the orgamc layers 
dried (MgSO,), filtered and evaporated. Purification 
by flash chromatography (sihca gel, hexanes : EtOAc; 
4.1) afforded 0.96 g (94%) of pure 10 as a colorless 
oil. ‘H-NMR (CDCl,) 6 7.65 (d, 2H, J = 8 4 Hz), 
7.32-7.29 (m, 2H), 7.10 (d, 2H, J = 8.1 Hz), 7 02-6.99 
(m,2H), 5.75 (d, lH, J=3 2Hz), 2.29 (d, lH, 
J = 3.4 Hz). Anal. calcd for (C,3H,0FIO) C, 47 58; 
H, 32.07. Found C, 47.74, H, 3 16 
4-Fluoro-4’-lodobenzhydryl chloride (11) 
A solution of 10 (0.73 g, 2 22 mmol) m dry CHCl, 
(5 mL) was treated m one portion at room tempera- 
ture under argon with excess SOCl, (5 mL,). The 
reaction mixture was refluxed for 2 h and volatiles 
were removed under reduced pressure The residue 
was partitioned between CHCl, (25 mL) and H,O 
(25 mL) The aqueous layer was further extracted 
with CHCl, and the combmed orgamc layers dried 
(Na,SO,), filtered and evaporated under reduced 
pressure Flash chromatography (silica gel, hex- 
anes:EtOAc 19 1) of the crude product gave 0 73 g 
(95%) of 11 as a colorless oil. ‘H-NMR (CDCl,) 6. 
7 68 (d, 2H, J = 8 5 Hz), 7.36-7 32 (m, 2H), 7.13 
(d,2H, J= 8.5Hz), 705-701 (m, 2H), 604 (s, 1H) 
HRMS m/e 345 9413 (C,,H,ClFI requires 345 9421) 
EIMS (70 eV) m/e (relative mtensity) 346(12), 
312(16), 3ll(base), 185(21), 184(43), 183(92), 182(12), 
92(20), 91(50), 86(34), 84(49), 82(20), 81(16), 63(17), 
51(14), 50(16), 49(25), 47(24), 39(14), 35(15). 
1-[2- {4- Fluorophenyl)(4- lodophenyl)methoxyjethyl]- 
4-(3-phenylpropyl)plperazme(l2) 
l-(2- hydroxyethyl)-4-(3 -phenylpropyl)piperazme 
(van der Zee et a[, 1980) (0.36 g, 1.44 mmol) and 11 
(0 50 g, 1.44 mmol) were combmed m a 1 mL glass 
V-vial (Pierce) sealed with a Teflon liner and cap and 
heated at 165°C for 45 mm. The dark brown residue 
was dissolved m the minimum volume of hot THF and 
added to a 100 mL mixture of Et,0 saturated brme 
(1 1). The Et,0 layer was removed, the aqueous layer 
extracted with Et,0 (1 x 50 mL) and the combined 
organic layers dried (Na,SO,), filtered and evapor- 
ated under reduced pressure Flash chromatography 
of the residue (sihca gel, CHCl, .CH,OH; 98.2) 
afforded 0.53 g (66%) of pure 12 as a pale yellow oil. 
A portion was converted to the dihydrochloride salt 
and recrystallized from isopropanol: Et,O, m.p. 
211-213°C (d). ‘H-NMR (free base, CDCl,) 6. 7.64 
(d, 2H, J=8.4Hz), 7.30-7.23 (m, 5H), 7 18 (d, 2H, 
J = 7.8 Hz), 7.06 (d, 2H, J = 8.4 Hz), 7.01-6.96 
(m, 2H), 5 29 (s, lH), 3 55 (t, 2H, J = 6.0 Hz), 2.67- 
2.34 (m, 14H), 1.81 (m,2H). Anal. calcd for 
(C28H32N2FI0.2HC1). C, 53.09; H, 5.41; N, 4.42. 
Found: C, 53.12; H, 5.58, N, 4.60. 
Radioiodtnatron 
In a typical procedure, a solution of (NH4)rS04 
(5.0mg m 15 PL of deionized HZO), 8a (2Opg of 
dihydrochlonde salt m 40 FL m EtOH), and 9.1 mCi 
of Na’251 were combmed and the mixture was heated 
to dryness at 145°C in an oil bath. Air was then 
slowly passed through the reaction vial for 2 min and 
the dry reaction mixture maintained at 145°C for 
25 mm. After coolmg, the reaction mixture was dis- 
solved m EtOH (250 p L) and subJected to radio-TLC 
analysis (silica; CHCl,: CH,OH; 19.1) The solution 
was passed through an anion-exchange column 
(Amberhte IRA 400, OH form, strongly basic) to 
remove residual [1251]iodide. Further elution with 
EtOH (250 pL) provided 5.41 mCi (59%) of crude 
radioactive product of ca 90% radiochemical purity. 
Further purification was accomplished by reversed 
phase HPLC as described which provided the tracers 
m 98% chemical and radiochemical purity as deter- 
mined by analytical HPLC. The HPLC purified 
radiotracers were diluted with 0 9% bacteriostatic 
salme to a final ethanol concentration of 10% for 
zn uzvo biological evaluations. 
The specific activity values (Cimmol-‘) and iso- 
lated radiochemical yields (shown m parentheses) for 
the radioiodmated tracers [‘2SI]8a, [‘2SI]8b, [“‘1]8c and 
[‘25I]12 were 200 (37%), 249 (SO%), 239 (57%) and 
266 (63%) respectively. 
Twue drstributlon studies 
CD-l mice (20-25 g, Charles River, Wilmington, 
MA) were injected via the tail vein under light ether 
anesthesia with either the fluorine-18 labeled hgands 
(7-1OpCi) or the iodine-125 labeled ligands 
(3-1OpCi). The animals were sacrificed by decapi- 
tation at designated time mtervals and the brain 
rapidly removed and dissected mto regions of interest 
(Glowinski and Iverson, 1966) (striatum, cerebral 
cortex, cerebellum and remainder of brain tissue). 
Blood samples were also obtained. All samples were 
assayed for radioactivity in an automatic y counter 
and then weighed. Data were calculated as % ID/g 
for all tissues. 
In vitro bmdmg studies 
In vztro competition studies for the binding of 
[‘H]GBR 12935 were performed as previously de- 
scribed (Richfield, 1991). Brains from adult male 
Sprague-Dawley rats (180-200 g) were obtained after 
rapid decapitation and frozen by immersion m 
isopentane at - 30°C. Brains were mounted on tissue 
pedestals and warmed to - 18°C coronal sections 
8-15 pm were cut on a cryostat microtome and thaw 
mounted onto gelatin coated slides. Slides were dehy- 
drated at 20°C for several minutes and then frozen at 
-25°C until used in assays. The final [3H]GBR 12935 
bmdmg buffer was a 50 mM sodium phosphate buffer 
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(pH 7 5) adjusted to a final sodium concentration of 
120 mM with sodium chlortde, 0 001% ascorbic acid, 
0.025% fatty acid free bovine serum albumin and 
0 75 PM trans-flupentixol Competition studies were 
performed at a [)H]GBR 12935 concentratron of 
0.25 nM and included various concentrations of un- 
labeled competrtors Equrhbrmm occurred at 30 h. 
Spectfic bmdmg was determined by subtracting the 
amount bound m the presence of 25 PM mazmdol 
(nonspecific bmdmg) from the amount bound m the 
absence of mazmdol (total bmdmg). Dried slides were 
placed m an x-ray cassette with carbon-14 plastic 
standards, previously calibrated with tritiated brain 
paste sections, and apposed to LKB ultrofilm ‘H at 
25°C for 21 days The LKB ultrofilm 3H was devel- 
oped m Kodak D19 for 4mm at room temperature 
and fixed m Kodak rapid fix for 3 5 mm All bindmg 
data were determined directly from film densities m 
regions of Interest usmg a video based densitometer 
(MCID BRS, Imagmg Research, Inc). Linear and 
nonlinear methods were used to determme mhibrtory 
constants (K,) One and two site nonhnear analyses 
were performed usmg computer assisted modeling 
program (London Software, Inc , Cleveland, OH) 
Competition models were constrained by having the 
K,, for [3H]GBR 12935 fixed to a smgle value deter- 
mmed by independent saturation experiments 
Results 
Chemutry and radrochemzstr~ 
Preparation of the fluorme-18 analogs with 
benzyl or phenethyl chants was straightforward. 
and followed the synthetic route (Scheme 2) that 
we have prevtously described for the preparation 
of the phenylpropyl compound [“F]GBR 13119 
(Haka et al, 1989. Kllbourn and Haka, 1988) The 
required I-phenylalkyl-4-(2-hydroxyethyl)prperazmes 
(2a, 2b or 2c) were prepared according to the pro- 
cedure of van der Zee et al. (1980) and reacted 
wtth 4-[“Flfluorobenzhydryl chlonde (Haka et al., 
1989). The final products, isolated by silica gel 
chromatography, were obtained in high radrochemi- 
cal purities (>95%) and high specrfic activtties 
(> 1000 Ci/mmol) 
The synthesis of the iodmated analogs was based 
on the methodology reported imtially by van der Zee 
and coworkers (van der Zee et al, 1980). The 
synthetic route outlined for the 3-rodophenylalkyl 
homologs 8a, 8b and 8c requrred the tosylate analogs 
6a, 6b and 6c, respectively, which were prepared as 
shown m Scheme 3. Drborane reduction of the ap- 
propriate 3-iodophenylalkanoic acid proceeded 
smoothly to give the alcohol which was converted to 
the tosylate by treatment with p-toluenesulfonyl 
chloride m pyrtdme/CH,Cl, Condensation of the 
tosylates 6a, 6b or 6c with 7 m the presence of K,C03 
m refluxmg toluene afforded 8a, 8b or 8c m 60-90% 
Isolated yields (Scheme 4) 
The synthesis of the analog bearing todme m the 
benzyhydryl portion of the molecule (12) utrhzed a 
different synthetic approach (Scheme 5) similar to 
that used m the preparation of the fluorine- 18 labeled 
compounds. Friedel-Crafts acylatron of fluoroben- 
zene with 4-rodobenzoyl chlortde gave 4-todo-4’- 
fluorobenzophenone 9 whrch was reduced wtth 
dlborane to the benzhydryl alcohol analog 10 Treat- 
ment of 10 with SOCI, m refluxmg CHCl, yielded the 
benzhydryl chloride 11, which was condensed wtth 
I-(3-phenylpropyl)-4-(2-hydroxyethyl)prperazme at 
165-C to afford 12 m 66% yield. Radrotodinatton was 
accomphshed by the ammomum sulfate catalyzed 
solid state Isotope exchange technique prevrously 
reported (Mangner et al, 1982) Unreacted Na12’I 
(CH,)n-COO” B”3 - Rl (CH,),-CH,OH 
THF 
&R, =H,R2=I,n=l 
&RR, q H,R,=l,n=2 
&RR, =l,R2=l+n=2 
5~ R,= H, R, = I, n = 1 
ti R, =H,R,=l,n=2 









m R, =H,R,=l,n=2 
& R, =l,R,=H,n=2 
Scheme 3 
New labeled dopamme uptake rnhibitors 
h R, =H,R,=l,n=2 
&Lk R1= H, R, = I, n = 3 
& R, q l,R,=H,n=3 
Scheme 4 
was removed by passage of an ethanol solution of 
the crude labeled product through an amon 
exchange column Further purtfication by reversed 
phase HPLC provided the radiohgands m 37-63% 
isolated radiochemical yield and 98% chemical and 
radiochemical purity. Specific activities were deter- 
mmed to be greater than 200 Cl mmoll ‘. All radio- 
iodmated ltgands showed less than 3% radiolytic 
decomposition when stored at 5°C m the HPLC 
elutton solvent (0 1 M ammonmm acetate, 
pH = 6.8:EtOH; 1:4) for up to 1 week The radio- 
tracers were formulated immediately prior to I v 
admimstratton by dtlutton wtth 0.9% bactertostatrc 
saline. 
In vitro btologrcal results 
The abilities of the new iodinated derivatives 8a-q 
12 and GBR 12909 to compete for [‘H]GBR 12935 
bindmg were determmed (Table 1). For compounds 
8a-b and 12, substitution with iodine produced a 
sigmficant (4- to 13-fold) loss in affinity. In the case 
of iodine substitution in the 4-position of the single 
aromatic nng (&), however, the in uztro affinity was 
not sigmficantly different from that of GBR 12909 
(13 nM). 
In vivo biological results 
The regtonal mouse brain distnbutions of the 
radiolabeled analogs are reported m Tables 2 and 3. 
Scheme 5 
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Table I Inblbmon of [“H]GBR 12935 
bmdmg by “armus GBR analogs 
Compound K,(nW 
8n 176 k I4 I 
8b 530* I4 1 
fk 214 * 12 3 
12 562+83 
GBR 12909 13290 
GBR 12935 I-2” 
aKd value from van der Zee PI a/ (1980) 
For the fluorme-18 labeled analogs (Table 2) no 
spectfic uptake and retention of the radiotracer m the 
strtatum was evident, with striatum-to-cerebellum 
concentration ratios near unity for both the benzyl 
(3a) and phenethyl (3b) compounds. Uptake and 
retention of radtotracer m nontarget tissue (cerebel- 
lum) and blood levels of radtoacttvity were not 
stgmficantly different from that we have previously 
reported with [18F]GBR 13119 or [“F]GBR 12909 
(Kilbourn, 1988, Haka er a/, 1989) 
For all of the radtoiodmated hgands (Table 3) the 
striatal accumulattons at 60 mm post-mlection were 
consistently less than 50% of that observed with 
[‘*F]GBR 13119, and the derivatives labeled m the 
solitary aromatic rmg all showed a much higher 
uptake of radioactivity m nontarget tissues such as 
the cerebellum and cortex With the iodine m the 
benzhydryl portion of the molecule, as m 12, levels of 
radioactivity m the nontarget tissues, cerebellum and 
cortex, were very stmtlar to those found with 
[r8F]GBR 13119 For all four iodmated radiotracers 
the strtatum-to-cerebellum concentration ratto never 
increased to greater than 1 The relative regional 
distrtbuttons of radioacttvtty did not change at later 
times, and with the exceptton of 8c, radioactivity 
levels slowly decreased with time. For the radtotodm- 
ated hgands, blood levels of radioactivity at 1 and 5 h 
were also comparable to those seen with [‘*F]GBR 
13119, except for 12 which dtsplayed much higher 
levels The Identity of the radioactivity m blood was 
not determined for any of the radiotodmated com- 
pounds 
Discussion 
The aryl-I ,4-dialkylptperazmes, exemphfied by 
GBR 12935 (Scheme 1, R, = R, = H), are the first 
reported dopamme reuptake mhtbitors having both 
high affinity and selectivity. In this study structural 
modifications were conducted on GBR 12935 to 
ascertain the effect on m vzvo selectivity of 
(1) chain length between the solitary phenyl rmg 
and the piperazme rmg; 
(2) location of the todme atom at various posttions 
on the aromatic rmgs 
The data shown m Table 2 forms a limited in uzuo 
structuredtstribution relattonship study of fluorme- 
18 labeled diarylalkylpiperazmes Dopammergic ter- 
minals are known to be highly concentrated m striatal 
tissue and vtrtually absent m the cerebellum 
(Grigoriadts ef al, 1989) The striatum to cerebellum 
concentratton ratio (STR/CER) therefore serves as a 
useful index of dopammergic spectfictty The goal of 
this study was to reduce the hpophihcity of [“F]GBR 
12909 and hopefully improve the target-to-nontarget 
(STR/CER) ratio Unexpectedly, the shortening of 
the phenylpropyl chain of [r*F]GBR 13119 by two 
(3a) or one (3b) methylene groups caused a complete 
loss of selective bmdmg of the radiotracer m mouse 
brain This was surprismg, since the origmal SAR 
study of this class of compounds (van der Zee et al, 
1980) reported only a 3-fold decrease m m vrtro 
bmdmg affinity m going from a phenylpropyl (GBR 
12935, IC,, = 2 nM) to the phenethyl analog 
(IC,, = 6 7 nM), although a larger decrease was re- 
ported for the benzyl analog (IC,, = 34 nM). The loss 
of specific zn CIUO bmdmg with such small changes m 
in z:rtro IC,, values is highly unusual For both of the 
chain-shortened analogs the striatal uptake of 
fluorme-18 was reduced to that of the cerebellum 
(giving STRjCER values near unity), and those levels 
were very comparable to the cerebellar levels found 
with [18F]GBR 13119, the parent phenylpropyl 
analog Thus, the low STRjCER ratios can be as- 
cribed to loss of specific bmdmg rather than increased 
nonspectfic bmdmg As all of these molecules are 
labeled m the same posttton, metabolic differences 
should be muumtzed All of the mono-fluoro 
compounds, GBR 13119, 3a and 3b, are choral but 
were studied as racemic mixtures, the influence of this 
chnahty on bmdmg to the DA uptake site IS 
unknown 
In Table 2 it can also be found for compartson the 
previously published regional brain distrtbuttons of 
[“F]GBR 12909 and a thiophene rmg substituted 
analog, thren~l-[r8F]GBR 13119, (1-[(4-[‘*F]fluoro- 
phenyl)(2-thlenyl)methoxy)ethyl]-4-(3-phenylpropyl) 
Table 2 In CM regmal braIn dlstrlbutmn of [“F]GBR analogs 60 mm after I v admmlstratmn to CD-l mlCed 
str1atum 
Compound Strlatum Cortex Cerebellum Blood Cerebellum % ID/Bram 
[“F]3n 0 67 k 0 03b 0 73 f 0 03 0 72 k 0 03 0 60 i 0 05 0 94 + 0 06 0 36 + 0 02 
[‘*F]3b 0 50 f 0 09 0 38 f 0 03 041 f004 0 73 + 0 06 117*0 I4 0 26 k 0 03 
[“F]3c (GBR I31 19) 28Oi_0 II 0 98 * 0 08 0 66 f 0 06 089+0 I6 4 24 k 0 48 0 44 * 0 04 
[‘SF]GBR 12909 I 82 * 0 59 091 *O I6 070*012 I 28 k 0 25 2 70 + 0 28 055&O I7 
Thtenyl-[‘*F]GBR 131 I9 2 50 F 0 35 10~021 063+016 0 78 -i_ 0 06 4 14kO48 0 47 + 0 05 
“3-28 ammals per data pomt 
bData reported as % ID/g (mean k SD) 
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Table 3 In uw regmnal bram dlstnbutmn of [“‘I]GBR Analogs after I v admmtstratlon to CD-I mIcea 
Time Stnatum 





10 106?0 13b 1 21 f 0 19 109*017 0 74 f 0 07 0 97 055~010 
50 013*003 016?004 0 12kOO3 0 28 k 0 02 I 08 007~001 
IO I 23 + 0 23 127kO 19 126kO 19 1 13 f 0 IO 0 98 059+008 
50 042kO II 041 f009 045fO II 0 87 f 0 05 0 93 020?005 
IO 116iO45 I 30 * 0 48 1 23 f 0 45 056+0 15 0 94 0 60 f 0 22 
50 1 77 + 0 49 222kO61 I 76 k 0 48 041 kOO8 I 00 0 95 f 0 26 
10 079*019 083fOl9 0 85 k 0 20 3 22 + 0 58 0 93 0 39 k 0 08 
50 0 40 + 0 05 0 43 + 0 05 0 43 + 0 07 2 48 f 0 30 0 93 022*002 
“3-5 ammals per data pomt 
bData reported as % ID/g (Mean f SD) 
ptperaztne) (Ktlbourn, 1989). We have conststently 
observed a lower striatal uptake and lower STRjCER 
ratio for [‘*F]GBR 12909 when compared with 
[“F]GBR 13119, even though these two compounds 
differ by only a smgle fluorine atom Different zn uivo 
behavior for such a small structural change was 
unexpected Fluorme substitutions on aromatic rings 
can have large effects on zn vzvo pharmacology where 
the strongly electron-withdrawing fluorine atom 
affects the iomzation of other rmg substituents 
(hydroxyls, ammes) or participates m through-space 
mteractions with groups on other portions of the 
molecule However, this should not be the case with 
GBR 12909, as such groups are absent A clear 
explanation of the lower selectivity of the his-fluoro 
analog IS thus lacking Fmally, the substitution of one 
of the phenyl rings wtth a thiophene nng provtdes a 
derivative with essentially the same zn vzvo distn- 
bution as [i8F]GBR 13119, mdicatmg that some 
modifications of the structure are tolerated 
Substitution of GBR 12935 and analogs with iod- 
me proved umformly unsuccessful, a complete loss of 
selective zn LVVO accumulation m the striatum was 
observed (Table 3) despite an zn vztro bmdmg affinity 
for compound 8c which was essentially identical to 
GBR 12909 The sensitivity of the dopamme uptake 
carrier bmdmg site to the length of the phenylalkyl 
cham, seen for the fluorine-18 compounds, was re- 
mforced by the rn vrtro bmdmg results for the 3-iodo 
analogs 8a (IC,, = 176 nM) and 8b (IC,, = 53 nM). 
The nonspecific bmdmg of compounds 8a-c, as evi- 
denced by radiotracer accumulation m cerebellum 
and cortex, is generally higher than that seen with the 
fluormated derivatives and this would be consistent 
with an expected Increase m the hpophilicity upon 
iodine substitution Surprismgly, substitution of an 
iodine for a fluorine, as m the conversion of GBR 
12909 to compound 12, did not increase the apparent 
nonspecific bmdmg, as radiotracer levels in cerebel- 
lum are quite similar Thus, although cerebellum 
radiotracer levels are a first approximation of 
nonspecific bmdmg, caution should be exercised m 
comparmg drfferent radiotracers due to possible 
differences m radiotracer metabohsm and delivery. 
This is perhaps supported by the very different blood 
level of radioactivity found for the sole analog 
with the iodme m the benzhydryl ether half of the 
molecule. 
The m vzvo btodtstnbution results obtained with 
the iodmated ligands are most easily explamed on the 
basis of a combmation of lower affinity for the 
dopamine uptake site and high nonspectfic bmdmg of 
these hpophilic compounds to hydrophobic cellular 
constituents. Recently, high affinity bmdmg of this 
class of drugs to a second site, identified as a cyto- 
chrome P450IIDl enzyme, has been reported during 
in vztro studies with [‘HI GBR 12935 (Nizmk et al., 
1990). Why the iodmation of GBR 12935 should 
increase binding to this site is unclear. It should be 
noted, however, that significantly different rn vivo 
biodistributions were observed for compounds 8b 
and &, which differ only m the position of the todme 
on the aryl nng The 4-iodophenylpropyl derivative 
8c contmues to accumulate m all brain tissues at 5 h, 
and even at 24 h does not return to the low levels 
observed with the isomenc compound 8b (data not 
shown). Clearly these two compounds, whrch should 
have nearly Identical physiochemical characteristics, 
show markedly different in VIVO behavior, whether 
this IS due to bmdmg to a second site, or result from 
dtfferences m metabolism and clearance, remains 
unresolved. We do know, based on thyroid radio- 
activity levels (data not shown), that the zn vivo 
deiodmation of these analogs 1 h after I.V. mJection IS 
low (< 5%) and thus does not likely contribute greatly 
to differences m the biodistributions of 8b and 8c 
These zn vivo studies have demonstrated some 
important requirements of the bmdmg site of the 
dopamme uptake carrier as they relate to design of 
new radiopharmaceuttcals. First, a three carbon- 
cham spacer between the piperazme nng nitrogen and 
the smgle phenyl rmg appears optimal for an zn vzvo 
radiotracer Second, large substituents such as todine 
can be tolerated with mmtmal losses of zn vztro 
bmdmg affimty, but such iodinated derivatives ex- 
hibit uniformly poor zn vzuo behavior Small sub- 
stituents such as fluorme at the 4’-positions of the 
diphenylmethoxy group (GBR 13 119, GBR 12909) 
are well tolerated, but large groups such as iodine 
have a negative effect These results complement the 
original SAR study of van der Zee et al. (1980) which 
showed decreases m in vztro binding affinmes upon 
substitutions with methyl, methoxy and chloro 
groups. 
In conclusion, the fluorme-18 labeled analogs pre- 
pared here do not appear to offer any advantage over 
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currently avallable radiotracers such as [‘*F]GBR 
13119 and [‘*F]GBR 12909 for m vtvo study of the 
dopamme reuptake system The radlolodmated 
denvatlves we have prepared also do not show prom- 
ise as hgands for SPECT lmagmg of the dopamme 
reuptake system 
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